{
    "Trade/Device Name(s)": [
        "EDIA\u2122 anti-CCP",
        "EDIA\u2122M anti-CCP"
    ],
    "Submitter Information": "Euro-Diagnostica AB",
    "510(k) Number": "K062045",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NHX"
    ],
    "Summary Letter Date": "July 14, 2006",
    "Summary Letter Received Date": "July 19, 2006",
    "Submission Date": "October 16, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5775"
    ],
    "Regulation Name(s)": [
        "Rheumatoid Factor Immunological Test System"
    ],
    "Analyte Class(es)": [
        "autoimmune",
        "immunology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Cyclic Citrullinated Peptides (CCP)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)"
    ],
    "Methodologies": [
        "Antibody detection",
        "Semi-quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for EDIA anti-CCP ELISA kit for detection of anti-CCP IgG antibodies to aid in diagnosis of rheumatoid arthritis.",
    "Indications for Use Summary": "The EDIA anti-CCP ELISA kit detects and semi-quantifies IgG antibodies to cyclic citrullinated peptides in serum and plasma as an aid to the diagnosis of rheumatoid arthritis, used with other clinical and laboratory findings.",
    "fda_folder": "Immunology"
}